{"disease":{"id":"vitreous-floaters","name":"vitreous floaters"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06964867","title":"Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Changzhou No.2 People's Hospital","has_results":false},{"nct_id":"NCT06174935","title":"Low Dose Atropine for Symptomatic Vitreous Floaters","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Jeanette Du","has_results":false},{"nct_id":"NCT07140692","title":"EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"The Eye Centers of Racine and Kenosha","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}